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INTRODUCTION
Intracellular-acting peptides have the potential to be applied as powerful research tools to modulate kinase activity, alter protein-protein interactions, and elucidate specific protein functions 6, 28, 32, 45 . Peptides can modulate targets not druggable by conventional small molecules and can be rationally designed to have more predictable and specific activity. However, clinical use of peptides is limited due to lack of intracellular bioavailability. This lack of bioavailability arises because peptides are too large and hydrophilic to diffuse across cell membranes. To overcome this barrier, the majority of peptides used in research are modified with cationic cell penetrating peptides (CPPs) to facilitate plasma membrane transduction 14, 16, 24 . Initial reports suggested that some CPPs may directly translocate the cell membrane, but later studies 39 showed this effect to be an artefact of microscopy. Upon endocytosis, CPPs typically traffic through early and late endosomes before ultimately becoming entrapped in lysosomes 22, 27 , sequestering a large portion of the drug away from its intracellular binding target. Many research groups have used polymeric nano-carriers to enable endo-lysosomal escape of biologic drugs like nucleic acids and peptides 12, 17 . Although debated, the 'proton sponge' mechanism of endosomal escape has been extensively described for nucleic acid delivery systems like polyethyleneimine 2, 7 ; however, the effects of endosomal escape on the subsequent trafficking of the drug cargo remain unclear 44 .
Anionic, pH-responsive carriers like the one described herein have been shown to reduce trafficking into acidifying compartments following CD22-dependent receptor mediated uptake 3 .
While the pharmacodynamics of anionic, polymer-based nano-polyplexes (NPs) used for the delivery of both an intracellular acting MAPKAP kinase 2 inhibitory (MK2i) peptide and a peptide mimetic of phosphorylated heat shock protein 20 (p-HSP20) have been thoroughly investigated 18, 19 , the mechanisms and kinetics of NP uptake and trafficking have not been rigorously studied. 
MATERIALS AND METHODS
Materials
Poly(propylacrylic acid) and MK2i were synthesized as previously reported 18, 19 . MK2i-NPs were formulated (Fig. 1a ) and characterized as previously described 18 . Eq. 1
Confocal Microscopy
Cells were plated at low confluence ( Nikon Perfect Focus System was used to ensure image focus. Image acquisition and analysis were performing using Nikon NIS-Elements AR version 4.30.01.
Scanning Electron Microscopy Imaging of Cellular Membrane Morphology
Samples were fixed in 2.5% gluteraldehyde in 0.1M cacodylate buffer (pH 7.4) at 37ºC for 1 hour and then transferred to 4ºC overnight. The samples were washed in 0.1M cacodylate buffer, incubated for 1 hour in 1% osmium tetraoxide at room temperature (RT), and then washed with 0.1M cacodylate buffer. Subsequently, the samples were dehydrated through a graded ethanol series followed by 3 exchanges of 100% ethanol. Samples were then critical point dried on a Tousimis samdri-PVT-3D critical point dryer and mounted on carbon adhesive attached to aluminum stubs. Samples were then sputter coated with gold/palladium for 90 seconds. Images were taken on FEI Quanta Q250 SEM.
Transmission Electron Microscopy Imaging of Cellular Uptake and Trafficking
Samples were fixed in 2.5% gluteraldehyde in 0.1M cacodylate buffer, pH7.4 at 37ºC for 1 hour then transferred to 4ºC, overnight. The samples were washed in 0.1M cacodylate buffer, then incubated 1 hour in 1% osmium tetraoxide at RT then washed with 0.1M cacodylate buffer.
Subsequently, the samples were dehydrated through a graded ethanol series, followed by 3 exchanges of 100% ethanol and 2 exchanges of pure propylene oxide (PO hours and then allowed to polymerize at 60°C for 48 hours. Samples were cut to 500 -1000 nm thick sections using a Leica Ultracut microtome. Thick sections were contrast stained with 1% toluidine blue and imaged with a Nikon AZ100 microscope to locate cells. 70-80 nm ultra-thin sections were cut and collected on 300-mesh copper grids and then post-stained with 2% uranyl acetate followed by Reynold's lead citrate. Thin samples were imaged on a Philips/FEI Tecnai T12 electron microscope.
Generation of Stably Transfected Cell Lines
Retroviral transfer plasmids encoding galectin/yellow fluorescent protein fusion proteins were kindly gifted by Felix Randow 43 . The retroviral packaging and pseudotyping vectors pUMVC and pCMV-VSV-G (Addgene.com Plasmid #8449 and #8454, respectively) were kind gifts of Bob 
Time Lapse Galectin 8 Microscopy
Single cell clonal populations were plated at 5,000 cells/well in chambered coverslips as described for confocal microscopy. Cells were monitored for 3-5 minutes to establish baseline Galectin 8 fluorescence. Cells were then treated for 30 minutes, after which the media was replaced. Live imaging was continued post-wash for at least 3 hours. Images were processed using the "spot detection" algorithm within Nikon NIS-Elements AR version 4.30.01 (Build 1021) and exported to Prism GraphPad and normalized to pre-treatment baseline fluorescence.
Statistics
Statistical analysis was performed via one-way ANOVA followed by Tukey's post-hoc test to compare experimental groups. Analyses were done with Microsoft Excel or Graphpad Prism 6 software. Statistical significance was accepted within a 95% confidence limit with a significance level of α = 0.05. Results are presented as arithmetic mean ± SEM graphically. For time-lapse galectin 8 recruitment data, statistical significance was defined by non-overlapping 95%
confidence intervals.
RESULTS
Characterization of Cellular Uptake Mechanisms
To confirm that the A7r5 rat aortic smooth muscle cell line recapitulates the uptake behavior of human coronary artery smooth muscle cells as previously reported 18, 19 (Fig.   1b) . These data recapitulate our previous results and validate that formulation of therapeutic CPPs into NPs increases peptide uptake by over an order of magnitude in vascular smooth muscle cells.
To confirm these differences qualitatively, we visualized cell peptide uptake by fluorescence confocal microscopy ( Fig. 1c and 1d) . To further understand the effects of NP formulation on MK2i uptake, a library of small molecule inhibitors of different endocytic pathways was used (see inhibitor descriptions in Table   1 ). Specifically, we sought to investigate: macropinocytosis, which has been implicated in CPP and nanoparticle internalization 26 and can be upregulated by cell surface receptor crosslinking 20, 38 ;
clathrin-and caveolin mediated endocytosis, which has been implicated in MK2i internalization 10, 22 ; lipid raft mediated endocytosis 10 , which has been implicated in MK2i internalization in some cell types; and scavenger receptor mediated uptake, which is known to be highly utilized in smooth muscle cells for uptake of negatively charged, hydrophobic particles like low-density lipoprotein that have similar physicochemical properties to PPAA-based MK2i-NPs 9,11,31 . 
Figure 2. MK2i-NPs enter cells through macropinocytosis while free MK2i exclusively utilizes clathrin mediated endocytosis. (a) Uptake inhibition of macropinocytosis, dynamin, and lipid rafts as measured by flow cytometry. Data is presented as mean fluorescence intensity relative to no treatment control. (b) Confocal micrographs of cells treated with MK2i-NP 10 µM and macropinocytosis inhibitors (c) scanning electron micrographs showing induction of cell surface ruffling indication macropinocytosis of MK2i-NPs
To confirm these results, live cells were treated with macropinocytosis inhibitors and visualized through confocal microscopy imaging (Fig. 2b) . Cells treated with any of the macropinocytosis inhibitors showed a marked decrease in the amount of large / macropinosomelike vesicles positive for MK2i-NP fluorescence (white arrows in Fig. 2b) . Because macropinocytosis is a process that involves re-organization of the actin cytoskeleton to form membrane protrusions (i.e., pseudopodia and membrane ruffling / blebbing) (Fig. 3) that engulf extracellular fluid, we sought to visualize this mechanism by SEM as previously reported 36 . Cells 
Clathrin mediated endocytosis and caveolin mediated endocytosis rely on a dynamin dependent closure step for internalization. MK2i-NP is proposed to enhance uptake by binding to external plasma membrane and internalize via macropinocytosis
were treated with 10 µM MK2i-NPs, MK2i, or PBS. As expected, MK2i-NPs, but not MK2i or PBS, induced a high degree of visible membrane ruffling (Fig. 2c) .
Transmission Electron Microscopy
TEM imaging was utilized for high resolution visualization of cellular ultrastructure during uptake and intracellular trafficking of gold-labeled MK2i-NPs (Au-MK2i-NPs). Au-MK2i-NP size equivalence with MK2i-NPs and gold loading (~98%) were confirmed by dynamic light scattering (DLS, Fig. S2 ). Gold-labeled MK2i peptide was excluded from TEM studies because of concerns that 10 nm gold would significantly affect trafficking of the individual peptide molecules, which are very small relative to the gold (i.e., 2 nm compared to 10 nm diameters for the peptide and gold, respectively). Furthermore, irreversible aggregation and precipitation were apparent upon mixing of the gold label with free MK2i peptide. Therefore, free gold was used as a control. Samples were treated for 30 minutes and thoroughly washed 1x with media and 5x with PBS. Samples were then either immediately fixed or incubated in fresh media for an additional 24 hours prior to fixation and processing.
TEM imaging shows that Au-MK2i-NPs are visibly clustered at the plasma membrane during uptake in cells fixed immediately after 30 minutes of treatment (Fig. 4.a.i. & 4.a. ii.). TEM images evinced structures consistent with macropinocytosis ( Fig. 4.a. iii & 4.a.iv.), which were not found in untreated or gold only samples (Fig. 4.d.i. & 4.d.iii. ). Au-MK2i-NPs are also found both contained within vesicular structures (Fig. 4.b. , black arrows) and in the cytosol at 30 minutes (Fig. 4.b. ii. & 4.b.iv., white arrows). At 24 hr. post-treatment, Au-MK2i-NPs are found within the cell both inside vesicular structures consistent with the endo-lysosomal system (Fig. 4.c. i.-iii., black arrows) and outside membrane bound vesicles (Fig. 4.c. ii-iv., white arrows), suggesting endosomal escape and cytosolic MK2i delivery. Although some Au-MK2i-NPs were found to reside within vesicles with clearly visible and intact membranes (Fig. 4.c. i., black arrows), they were also commonly associated with vesicles with disrupted membranes [i.e., only partial membranes (Fig. 4.c. ii., black arrows) or fragmented membranes (Fig. 4.c. iii., all particles)]. These damaged and swollen vesicles found in Au-MK2i-NP treated cells are in clear contrast to untreated or gold only treated control cells (Figs. 4.d.i-iv.) . These are the first high-resolution electron micrographs, to our knowledge, that enable visualization of the endosomal disruption activity of the highly-utilized endosomolytic polymer PPAA. 
Real-time Monitoring of Endosomal Escape
To determine the temporal kinetics of endosomal escape revealed by TEM, a novel livecell fluorescent imaging methodology based on intracellular localization of galectin-8 (Gal8) was performed to assess endosomal membrane damage during MK2i-NP treatment. Gal8 is a β-galactoside-binding lectin of the galectin family, and is normally normally localized diffusely throughout the cytosol and secreted, binding to glycans in the extracellular space to influence cell behavior 1 . They also serve as part of the innate immune to sense exposed intracellular glycans 43 , which is relevant to the current application in that glycans are naturally located on the external plasma membrane or enclosed within vesicles (e.g., on the luminal surfaces of endosomes, macropinosomes, etc.). When endosomes are disrupted by pathogens (e.g., bacteria) 43 or transfection reagents (e.g., Lipofectamine) 47 , Gal8 binds to glycans on the exposed luminal surface of the endosomal membrane and induces macroautophagy (i.e., sequestration in a de novo generated double-membraned autophagosome 8 that fuses with lysosomes to facilitate degradation of the autophagosomal contents). In 2015, Wittrup et al. 47 showed that Lipofectamine lipoplexes induce endosomal damage at the Rab 5 to Rab 7 conversion step, at which point, nucleic acids are released into the cytosol. These studies also showed that the transient leakiness of damaged endosomes results in detectible recruitment of galectin-8 due to accessibility to glycans within the endosomal lumen. Based on this method, A7r5 cells were generated that stably express Gal-8-YFP, enabling real time monitoring and quantification of endosomal disruption in vascular smooth muscle cells (Fig. 5a) . Treatment with MK2i-NPs, but not free MK2i peptide, rapidly induced recruitment of Gal8 to intracellular vesicles (bright punctate staining in Fig. 5b ), whereas treatment with free MK2i peptide showed no appreciable changes over time. We also located, in MK2i-NP-treated cells, double membrane structures consistent with autophagosomes merging with electron dense vesicles consistent with lysosomes 30 minutes after treatment (Fig. 6) . herein were designed to gain mechanistic insight into how NP formulation influences the cellular uptake and intracellular trafficking of the MK2i peptide to realize a more effective peptide-based therapy. By elucidating the mechanism of MK2i-NP uptake and trafficking, we can potentially efficacy so that they can be more broadly applied to improve the intracellular delivery of peptides and other biomacromolecular therapeutics.
DISCUSSION
Flow cytometry based analysis of MK2i-NP uptake verified that NP formulation significantly increased MK2i uptake in A7r5 rat aortic smooth muscle cells 49-fold (Fig. 1b) , hypothesized that scavenger receptors may be responsible for the observed increase in peptide uptake. However, two separate scavenger receptor inhibitors, polyinosinic acid and dextran sulfate, were found to have no influence on MK2i-NP uptake. In agreement with previous studies 10, 22 , uptake of the MK2i peptide appeared to be dependent on clathrin-and/or caveolae mediated endocytosis and independent of macropinocytosis. In contrast, MK2i-NP uptake was found to be dependent on both macropinocytosis and clathrin-and/or caveolae mediated endocytosis.
Electron microscopy studies confirmed that macropinocytosis as an underlying mechanism of enhanced uptake of MK2i-NPs. SEM analysis of MK2i-NP treated cells confirm the induction of macropinocytosis as evinced by appearance of membrane ruffling, blebbing, and protrusions that were not present in untreated cells or cells treated with the free MK2i peptide (Fig. 2c) . TEM analysis further supported macropinocytosis as a differential mechanism of MK2i-NP uptake.
Gold-labeled Au-MK2i-NPs were found to strongly associate with areas of the cell membrane that displayed membrane ruffling, membrane blebbing, and pseudopodia. Furthermore, Au-MK2i-NPs were found within large diameter (i.e., ~500 nm) vesicular compartments consistent with morphology of macropinosomes (Fig. 4b.i-iv., 4ci-iii.) .
Macropinosomes have been reported to be inherently more leaky than endosomes 27 , so we Gal8 recruitment. In turn, Gal8 recruits NDP52 and LC3 proteins that are responsible for the formation of a secondary containment membrane around the damaged endosome 43, 47 , which is then rapidly trafficked to terminal lysosomes 4, 8, 23, 40 . Our data further supports the importance of identifying the role autophagosomal encapsulation of damaged endosomes plays in the delivery of biomacromolecular therapeutics and may help to explain the discrepancy between the 49-fold enhancement in uptake paired with the approximately 10-fold enhancement in bioactivity.
Autophagosomal escape may represent a viable pathway for further enhancement of intracellular bioavailability of biomacromolecules delivered via endosomolytic carriers.
In conclusion, our data demonstrate that formulation of a therapeutic MK2i peptide into a slightly hydrophobic, pH-responsive NPs enhances uptake through enhanced cellular membrane association and macropinocytosis. This enhanced membrane association is hypothesized to be a result of the hydrophobic nature of the PPAA polymer causing interactions with lipids in the cell membrane. Furthermore, the pH-responsive behavior of the PPAA polymer results in pH-triggered endo-lysosomal disruption following cellular internalization, observed by TEM as both escape and disruption of membrane morphology. The endosomal disruption of MK2i-NP was further supported by Gal8 recruitment and subsequent trafficking into autophagosomes. Therefore, these studies suggest that formulation of MK2i into NPs significantly increases peptide uptake and facilitates endosomal escape by influencing both the mechanism of cellular uptake and intracellular trafficking. Endosomal escape not only prevents endo-lysosomal degradation and/or exocytosis via recycling endosomes, but also increases intracellular bioavailability. These studies suggest that macropinocytosis may be a very efficient route of entry for biologic drugs and that macropinosomes can be escaped by endosomolytic carriers. Further, Gal8 recruitment may be a useful assay for identifying critical structure-function relationships between nano-scale drug delivery carriers and bioactivity, and may prove useful in screening the endosomolytic properties of nanoscale drug carriers. We show that endosomolytic carriers still suffer from partial lysosomal entrapment due to autophagosomal encapsulation of damaged endosomes followed by lysosomal trafficking. This result suggests that autophagosomal trafficking and sequestration may be another critical barrier in the delivery of cytosolic therapeutics; inhibiting this process may represent a high potential target for further enhancements to intracellular bioavailability of cytosolic-acting biologic therapeutics.
Finally, further research into the structure-function relationships of peptide nanopolyplexes is warranted. PPAA has been shown to be applicable to multiple peptides 19 , though it is unknown whether PPAA alters intracellular trafficking for all biomacromolecular cargo in similar manner. Efficient delivery of protein and peptide drugs to cytosolic targets remains a critical barrier in the clinical translation of cytosol acting peptide drugs. Even the strongest endosomolytic agents are only partially efficient at cytosolic delivery and endosomal escape and may be limited in their delivery efficiency by autophagosome sequestration mechanisms.
